<乌鸦传媒>Which IBD Patients Experience More Severe COVID? Research suggests immunomodulators, incomplete vaccination, and non-mRNA vaccines may play a role Jan 21, 2022
<乌鸦传媒>Crohn's Disease Scores With Interchangeable Humira Biosimilar "Non-medical switches" will be less of a concern when new treatment option becomes available Dec 31, 2021
<乌鸦传媒>Non-Invasive Nerve Stimulation Shows Promise for Younger IBD Patients Small pilot study found many children and young adults achieved clinical remission Dec 15, 2021
<乌鸦传媒>Year in Review: Crohn's Disease First interchangeable biosimilar approved, biologics go head-to-head Dec 15, 2021
<乌鸦传媒>For IBD Patients, Too Much Processed Meat May Be Deadly Study investigates diet's link to all-cause mortality, not just IBD incidence Dec 14, 2021
<乌鸦传媒>No Extra C. Diff Risk Observed With Vedolizumab in Ulcerative Colitis Retrospective study found no increased risk versus anti-TNF agents, but more research is needed Dec 11, 2021
<乌鸦传媒>Time Doesn't Heal Parents' Mental Health Wounds From Kids' IBD Dx "I was surprised" by these results, researcher says Dec 10, 2021
<乌鸦传媒>Biologics vs Small Molecule Drugs for UC: Which Agent Emerged on Top? The most effective drug not necessarily the safest Dec 01, 2021
<乌鸦传媒>JAK Inhibitor Maintenance Works in Severe Ulcerative Colitis Treatment group achieved clinical remission, met clinical secondary endpoints Oct 29, 2021
<乌鸦传媒>Maintenance IL-23 Blockade Yields Durable Benefit in Crohn's Disease Over 50% of patients responding to induction risankizumab maintained clinical remission at 1 year Oct 28, 2021
<乌鸦传媒>How Should Patients With Autoimmune Diseases Approach COVID Vaccination? Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
<乌鸦传媒>First Interchangeable Humira Biosimilar Approved Cyltezo nabs coveted "interchangeable" status for RA, inflammatory bowel disease, and more Oct 18, 2021
<乌鸦传媒>IBD and Pediatric Arthritis: Exploring the Link Risk factors include enthesitis, family history, and etanercept use Sep 15, 2021
<乌鸦传媒>FDA Slaps Restrictions on JAK Inhibitors Over Serious Safety Risks Use for inflammatory conditions limited to those who fail on TNF blockers Sep 01, 2021
<乌鸦传媒>Proton Pump Inhibitors and IBD: What's the Link? Use tied to "modest" increase in risk for ulcerative colitis, Crohn's in observational studies Aug 12, 2021
<乌鸦传媒>COVID-19 Antibody Response in IBD Patients Quickly Wanes Canadian study emphasizes importance of vaccination in this population, researcher says Aug 04, 2021
<乌鸦传媒>Two Ulcerative Colitis Biologics: Same Clinical Difference? One may have additional clinical benefits, post-hoc analysis suggested Aug 02, 2021
<乌鸦传媒>New-Onset IBD and IL-17 Inhibitors: What Is the Risk? Underlying inflammatory disease severity should be taken into account Jul 21, 2021
<乌鸦传媒>Pope Francis's Diverticular Disease A look at the pontiff's recent medical condition Jul 20, 2021
<乌鸦传媒>Shingles Risk Slashed in IBD Patients After Vaccine Study found certain medications also showed lower incidence rates Jul 20, 2021
<乌鸦传媒>PURE Study Points Finger at Processed, Fatty Foods in IBD But expert serves up a heaping helping of caveats to the findings Jul 14, 2021
<乌鸦传媒>Adults With Obesity See Increased Risk for Crohn's Disease Growing obesity burden may contribute to rise in Crohn's incidence, researcher suggests Jul 08, 2021
<乌鸦传媒>Did Fecal Transplant Stop COVID in Its Tracks? Two Polish patients co-infected with C difficile saw improvements Jul 06, 2021
<乌鸦传媒>No Difference in Disease Markers for IBD Patients Treated With Biosimilars U.K. study shows comparable results after a year Jun 10, 2021
<乌鸦传媒>Tofacitinib May Cut Colectomy Risk in Hospitalized, Severe UC Small study found that patients appeared to benefit from limited-duration high-intensity therapy Jun 01, 2021
<乌鸦传媒>Perianal Involvement in Crohn鈥檚 Disease: How Bad for Prognosis? Poor outcomes noted, especially with severe phenotype Apr 14, 2021
<乌鸦传媒>Refractory IBD: The Case for Doubling Up on Drugs Meta-analysis suggests select patients can avoid surgery Apr 01, 2021
<乌鸦传媒>Game Changer for Ulcerative Colitis Patients Failing Anti-TNF? JAK inhibitor helped when biologic didn't Mar 12, 2021
<乌鸦传媒>Vedolizumab Tied to Lower Risk for Serious Infections in Ulcerative Colitis But positive association versus TNF inhibitors not seen in Crohn's disease Mar 01, 2021
<乌鸦传媒>JAK Inhibitor Misses Endpoint in Safety Study. Now What? Major blow to popular class of oral rheumatology drugs Jan 27, 2021
<乌鸦传媒>IBD and COVID: Kids Do Well International registry shows older age, comorbidities are risks; anti-TNF might protect Jan 25, 2021
<乌鸦传媒>For Seniors with IBD, Think Safety With Treatments Hospitalizations risks were lower with vedolizumab than TNF inhibitors Jan 24, 2021
<乌鸦传媒>Diets Ease Symptoms in Crohn's Both the Mediterranean and Specific Carbohydrate diets were helpful in mild to moderate disease Jan 24, 2021
<乌鸦传媒>Low-Dose IL-2 Shows Promise in Colitis Safety and response seen in dose-ranging ulcerative colitis trial Jan 23, 2021
<乌鸦传媒>IBD and COVID-19: Who Is at Risk? Worse outcomes for older patients and those with comorbidities and on steroids Dec 12, 2020
<乌鸦传媒>Can Some Treatments Be Stopped in IBD? With combination therapy, some patients successfully withdrew the TNF inhibitor Dec 11, 2020
<乌鸦传媒>Ozanimod a Winner in Ulcerative Colitis S1P receptor modulator effective for both induction and maintenance Dec 10, 2020
<乌鸦传媒>Smoking Worsens Crohn's Disease Smokers were more likely to have stricturing or penetrating disease, Canadian study showed Dec 10, 2020
<乌鸦传媒>More Evidence Early Mortality Persists in IBD Canadian study shows treatment advances haven't erased lifespan deficit Nov 09, 2020
